Filing Details
- Accession Number:
- 0001140361-17-014775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-05 12:18:51
- Reporting Period:
- 2017-04-03
- Filing Date:
- 2017-04-05
- Accepted Time:
- 2017-04-05 12:18:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501989 | Cytomx Therapeutics Inc. | CTMX | Pharmaceutical Preparations (2834) | 273521219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654058 | A. Sean Mccarthy | 151 Oyster Point Blvd. Suite 400 South San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-03 | 4,781 | $0.95 | 6,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-03 | 4,781 | $16.94 | 1,979 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-04-04 | 4,781 | $0.95 | 6,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-04 | 4,781 | $17.50 | 1,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-04-03 | 4,781 | $0.00 | 4,781 | $0.95 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-04-04 | 4,781 | $0.00 | 4,781 | $0.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,634 | 2023-02-25 | No | 4 | M | Direct | |
| 72,853 | 2023-02-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 158,737 | Indirect | See footnote |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.71 to $17.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Held in McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees.
- 100% of the shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
